NOTCH1 Mutations Predict Superior Outcomes of Immune Checkpoint Blockade in Non-Small Cell Lung Cancer

Qingyuan Huang,1– 3,* Hang Cao,1– 3,* Qianlan Yao,3– 5,* Xiaoyan Zhou,3– 5 Hang Li,1– 3 Qianming Bai,3– 5 Hong Hu1– 3 1Departments of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China; 2Institute of Thoracic Oncology, Fuda...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:ImmunoTargets and Therapy
المؤلفون الرئيسيون: Huang Q, Cao H, Yao Q, Zhou X, Li H, Bai Q, Hu H
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Dove Medical Press 2023-12-01
الموضوعات:
notch1
non-small cell lung cancer
immunotherapy
survival
tumor mutational burden
tumor microenvironment
الوصول للمادة أونلاين:https://www.dovepress.com/notch1-mutations-predict-superior-outcomes-of-immune-checkpoint-blocka-peer-reviewed-fulltext-article-ITT

الانترنت

https://www.dovepress.com/notch1-mutations-predict-superior-outcomes-of-immune-checkpoint-blocka-peer-reviewed-fulltext-article-ITT

مواد مشابهة